0001012975-18-000006.txt : 20180102
0001012975-18-000006.hdr.sgml : 20180102
20180102170950
ACCESSION NUMBER: 0001012975-18-000006
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20171228
FILED AS OF DATE: 20180102
DATE AS OF CHANGE: 20180102
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SCHAFFER DERACE L
CENTRAL INDEX KEY: 0001031735
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090]
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32587
FILM NUMBER: 18502553
MAIL ADDRESS:
STREET 1: C/O ALLION HEALTHCARE, INC.
STREET 2: 1660 WALT WHITMAN ROAD, SUITE 105
CITY: MELVILLE
STATE: NY
ZIP: 11747
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Altimmune, Inc.
CENTRAL INDEX KEY: 0001326190
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 202726770
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 19 FIRSTFIELD ROAD
CITY: GAITHERSBURG
STATE: MD
ZIP: 20878
BUSINESS PHONE: 2406541450
MAIL ADDRESS:
STREET 1: 19 FIRSTFIELD ROAD
CITY: GAITHERSBURG
STATE: MD
ZIP: 20878
FORMER COMPANY:
FORMER CONFORMED NAME: PHARMATHENE, INC
DATE OF NAME CHANGE: 20071016
FORMER COMPANY:
FORMER CONFORMED NAME: HEALTHCARE ACQUISITION CORP
DATE OF NAME CHANGE: 20050505
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2017-12-28
0001326190
Altimmune, Inc.
ALT
0001031735
SCHAFFER DERACE L
C/O ALTIMMUNE, INC.
19 FIRSTFIELD ROAD, SUITE 200
GAITHERSBURG
MD
20878
1
0
0
0
Common Stock, par value $0.0001
2017-12-28
4
P
0
58711
1.9191
A
550754
D
Common Stock, par value $0.0001
2017-12-29
4
P
0
38699
1.9323
A
589453
D
Common Stock, par value $0.0001
12393
I
IRA
The price reflected is the weighted-average purchase price for shares purchased. The range of purchase prices for the transactions reported was $1.76 to $2.00 per share. The Reporting Person undertakes to provide, upon request by the Issuer, any security holder of the Issuer, or the SEC staff, full information regarding the number of shares purchased at each separate price.
The price reflected is the weighted-average purchase price for shares purchased. The range of purchase prices for the transactions reported was $1.90 to $1.98 per share. The Reporting Person undertakes to provide, upon request by the Issuer, any security holder of the Issuer, or the SEC staff, full information regarding the number of shares purchased at each separate price.
/s/ Ori Solomon, Attorney in fact for Derace Schaffer
2018-01-02